MediPharm Labs Corp.
MEDIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $33,383 | $28,247 | $40,132 | $24,651 |
| - Cash | $10,584 | $10,362 | $8,443 | $11,690 |
| + Debt | $423 | $542 | $125 | $388 |
| Enterprise Value | $23,222 | $18,427 | $31,814 | $13,349 |
| Revenue | $11,448 | $11,808 | $10,806 | $12,042 |
| % Growth | -3% | 9.3% | -10.3% | – |
| Gross Profit | $2,562 | $3,330 | $4,182 | $3,616 |
| % Margin | 22.4% | 28.2% | 38.7% | 30% |
| EBITDA | -$1,706 | -$3,339 | $54 | -$1,144 |
| % Margin | -14.9% | -28.3% | 0.5% | -9.5% |
| Net Income | -$2,142 | -$3,770 | -$387 | -$1,726 |
| % Margin | -18.7% | -31.9% | -3.6% | -14.3% |
| EPS Diluted | -0.01 | -0.009 | -0.001 | -0.004 |
| % Growth | -9.9% | -911.1% | 78.6% | – |
| Operating Cash Flow | -$158 | -$2,769 | -$3,012 | -$1,067 |
| Capital Expenditures | -$16 | -$42 | -$42 | -$44 |
| Free Cash Flow | -$174 | -$2,811 | -$3,054 | -$1,111 |